D-Index & Metrics Best Publications

D-Index & Metrics

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Medicine D-index 137 Citations 72,148 1,022 World Ranking 760 National Ranking 462

Overview

What is he best known for?

The fields of study he is best known for:

  • Internal medicine
  • Cancer
  • Surgery

Morie A. Gertz mainly investigates Internal medicine, Multiple myeloma, Surgery, Gastroenterology and Amyloidosis. Morie A. Gertz has included themes like Immunology and Oncology in his Internal medicine study. The various areas that Morie A. Gertz examines in his Multiple myeloma study include Dexamethasone and Pathology.

His study in Surgery is interdisciplinary in nature, drawing from both Hematology and Clinical trial. The Gastroenterology study combines topics in areas such as Creatinine, Progressive disease, Survival analysis and Neutropenia. The concepts of his Amyloidosis study are interwoven with issues in Nephrotic syndrome, Heart failure, AL amyloidosis and Hematologic Response.

His most cited work include:

  • International uniform response criteria for multiple myeloma (2049 citations)
  • Improved survival in multiple myeloma and the impact of novel therapies (1718 citations)
  • Review of 1027 Patients With Newly Diagnosed Multiple Myeloma (1515 citations)

What are the main themes of his work throughout his whole career to date?

The scientist’s investigation covers issues in Internal medicine, Multiple myeloma, Surgery, Amyloidosis and Oncology. Internal medicine and Gastroenterology are frequently intertwined in his study. His studies deal with areas such as Survival rate and Survival analysis as well as Gastroenterology.

His work focuses on many connections between Multiple myeloma and other disciplines, such as Dexamethasone, that overlap with his field of interest in Cyclophosphamide. The study incorporates disciplines such as Immunoglobulin light chain, Amyloid, Primary systemic amyloidosis and Immunoglobulin Light-chain Amyloidosis in addition to Amyloidosis. His Oncology study integrates concerns from other disciplines, such as Waldenstrom macroglobulinemia, Newly diagnosed, Clinical trial and Rituximab.

He most often published in these fields:

  • Internal medicine (62.03%)
  • Multiple myeloma (46.38%)
  • Surgery (27.54%)

What were the highlights of his more recent work (between 2017-2021)?

  • Internal medicine (62.03%)
  • Multiple myeloma (46.38%)
  • Amyloidosis (26.43%)

In recent papers he was focusing on the following fields of study:

Morie A. Gertz focuses on Internal medicine, Multiple myeloma, Amyloidosis, Oncology and AL amyloidosis. As part of his studies on Internal medicine, Morie A. Gertz frequently links adjacent subjects like Gastroenterology. His research investigates the connection between Gastroenterology and topics such as Cohort that intersect with problems in Hazard ratio.

His Multiple myeloma research is multidisciplinary, incorporating perspectives in Hematopoietic stem cell transplantation, Newly diagnosed, Survival analysis and Bone marrow. His work carried out in the field of Amyloidosis brings together such families of science as Immunoglobulin light chain, Very Good Partial Response, Transthyretin and Amyloid. His Oncology research incorporates themes from Waldenstrom macroglobulinemia, Clinical trial, Rituximab and Daratumumab.

Between 2017 and 2021, his most popular works were:

  • Management of relapsed and refractory multiple myeloma: novel agents, antibodies, immunotherapies and beyond (131 citations)
  • Risk stratification of smoldering multiple myeloma incorporating revised IMWG diagnostic criteria. (67 citations)
  • Immunoglobulin light chain amyloidosis diagnosis and treatment algorithm 2018. (47 citations)

In his most recent research, the most cited papers focused on:

  • Internal medicine
  • Cancer
  • Disease

His primary areas of investigation include Internal medicine, Amyloidosis, Multiple myeloma, AL amyloidosis and Gastroenterology. Many of his studies involve connections with topics such as Oncology and Internal medicine. He interconnects Immunoglobulin light chain, Transthyretin, Polyneuropathy and Amyloid in the investigation of issues within Amyloidosis.

As part of the same scientific family, he usually focuses on Multiple myeloma, concentrating on Hazard ratio and intersecting with Surgery. His AL amyloidosis research includes elements of Survival rate, Stem cell, Retrospective cohort study and Very Good Partial Response. His study on Gastroenterology also encompasses disciplines like

  • Bone marrow which is related to area like Myeloma protein,
  • Hematopoietic stem cell transplantation that connect with fields like Melphalan.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

International uniform response criteria for multiple myeloma

B. G. M. Durie;J.-L. Harousseau;J. S. Miguel;J. Blade.
Leukemia (2006)

2975 Citations

Review of 1027 Patients With Newly Diagnosed Multiple Myeloma

Robert A. Kyle;Morie A. Gertz;Thomas E. Witzig;John A. Lust.
Mayo Clinic Proceedings (2003)

2466 Citations

Improved survival in multiple myeloma and the impact of novel therapies

Shaji K. Kumar;S. Vincent Rajkumar;Angela Dispenzieri;Martha Q. Lacy.
Blood (2008)

2418 Citations

CRITERIA FOR EVALUATING DISEASE RESPONSE AND PROGRESSION IN PATIENTS WITH MULTIPLE MYELOMA TREATED BY HIGH‐DOSE THERAPY AND HAEMOPOIETIC STEM CELL TRANSPLANTATION

Joan BladÉ;Diana Samson;Donna Reece;Jane Apperley.
British Journal of Haematology (1998)

1935 Citations

Continued improvement in survival in multiple myeloma: changes in early mortality and outcomes in older patients

S K Kumar;A Dispenzieri;M Q Lacy;M A Gertz.
Leukemia (2014)

1058 Citations

International Myeloma Working Group guidelines for serum-free light chain analysis in multiple myeloma and related disorders

A. Dispenzieri;R. Kyle;G. Merlini;J. S. Miguel.
Leukemia (2009)

866 Citations

POEMS syndrome: definitions and long-term outcome.

Angela Dispenzieri;Robert A. Kyle;Martha Q. Lacy;S. Vincent Rajkumar.
Blood (2003)

832 Citations

A Trial of Three Regimens for Primary Amyloidosis: Colchicine Alone, Melphalan and Prednisone, and Melphalan, Prednisone, and Colchicine

Robert A. Kyle;Morie A. Gertz;Philip R. Greipp;Thomas E. Witzig.
The New England Journal of Medicine (1997)

824 Citations

Combination therapy with lenalidomide plus dexamethasone (Rev/Dex) for newly diagnosed myeloma.

S. Vincent Rajkumar;Suzanne R. Hayman;Martha Q. Lacy;Angela Dispenzieri.
Blood (2005)

806 Citations

Serum Cardiac Troponins and N-Terminal Pro-Brain Natriuretic Peptide: A Staging System for Primary Systemic Amyloidosis

Angela Dispenzieri;Morie A. Gertz;Robert A. Kyle;Martha Q. Lacy.
Journal of Clinical Oncology (2004)

757 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Morie A. Gertz

Meletios A. Dimopoulos

Meletios A. Dimopoulos

National and Kapodistrian University of Athens

Publications: 396

Kenneth C. Anderson

Kenneth C. Anderson

Harvard University

Publications: 337

Paul G. Richardson

Paul G. Richardson

Harvard University

Publications: 328

Giampaolo Merlini

Giampaolo Merlini

University of Pavia

Publications: 259

Philippe Moreau

Philippe Moreau

University of Nantes

Publications: 240

Shaji Kumar

Shaji Kumar

Mayo Clinic

Publications: 239

Antonio Palumbo

Antonio Palumbo

University of Turin

Publications: 238

S. Vincent Rajkumar

S. Vincent Rajkumar

Mayo Clinic

Publications: 235

Angela Dispenzieri

Angela Dispenzieri

Mayo Clinic

Publications: 222

Evangelos Terpos

Evangelos Terpos

National and Kapodistrian University of Athens

Publications: 211

Hartmut Goldschmidt

Hartmut Goldschmidt

University Hospital Heidelberg

Publications: 208

Gareth J. Morgan

Gareth J. Morgan

New York University

Publications: 194

Robert A. Kyle

Robert A. Kyle

Mayo Clinic

Publications: 193

Michele Cavo

Michele Cavo

University of Bologna

Publications: 188

Jesús F. San Miguel

Jesús F. San Miguel

University of Navarra

Publications: 187

Joan Bladé

Joan Bladé

University of Barcelona

Publications: 186

Trending Scientists

Rajarshi Gupta

Rajarshi Gupta

Amazon Web Services

Shichao Zhang

Shichao Zhang

Beihang University

Ming Tang

Ming Tang

East China Normal University

Siani Pearson

Siani Pearson

Siani Pearson Consulting

Edward J. Bouwer

Edward J. Bouwer

Johns Hopkins University

Lisa Alvarez-Cohen

Lisa Alvarez-Cohen

University of California, Berkeley

Renato Zenobi

Renato Zenobi

ETH Zurich

Wayde N. Martens

Wayde N. Martens

Queensland University of Technology

Tai-Chang Chiang

Tai-Chang Chiang

University of Illinois at Urbana-Champaign

Lee L. Rubin

Lee L. Rubin

Harvard University

Alexander V. Babanin

Alexander V. Babanin

University of Melbourne

Christine Wiedinmyer

Christine Wiedinmyer

University of Colorado Boulder

Jose D. Fuentes

Jose D. Fuentes

Pennsylvania State University

Michel Cuenod

Michel Cuenod

University of Lausanne

Nancy L. Haigwood

Nancy L. Haigwood

Oregon National Primate Research Center

Esme Moniz-Cook

Esme Moniz-Cook

University of Hull

Something went wrong. Please try again later.